Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where James Hulsizer is active.

Publication


Featured researches published by James Hulsizer.


Bioorganic & Medicinal Chemistry Letters | 2012

Multiparameter exploration of piperazine derivatives as δ-opioid receptor agonists for CNS indications

John Mccauley; Cathy Dantzman; Megan M. King; Glen Ernst; Xia Wang; Kelly Brush; William E. Palmer; William Frietze; Donald W. Andisik; Valerie Hoesch; Kenneth Doring; James Hulsizer; Khanh Bui; Jay Liu; Thomas J. Hudzik; Steven Wesolowski

A novel series of piperazine derivatives exhibits sub-nanomolar binding and enhanced subtype selectivity as δ-opioid agonists. The synthesis and SAR are described as well as the application of computational models to improve in vitro ADME and safety properties suitable for CNS indications, specifically microsomal clearance, permeability, and hERG channel inhibition.


Journal of Medicinal Chemistry | 1997

Orally Active Trifluoromethyl Ketone Inhibitors of Human Leukocyte Elastase

Chris Allan Veale; Peter R. Bernstein; Claudia M. Bohnert; Frederick Jeffrey Brown; Craig Bryant; James R. Damewood; Roger Earley; Scott W. Feeney; Philip Duke Edwards; Bruce Gomes; James Hulsizer; Ben J. Kosmider; Robert D. Krell; Gary Moore; Theodora W. Salcedo; Andrew Shaw; David S. Silberstein; Gary Steelman; Mark Morris Stein; Anne M. Strimpler; Roy M. Thomas; Edward P. Vacek; Joseph C. Williams; Donald John Wolanin; Sheila Woolson


Journal of Medicinal Chemistry | 1996

N-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP Potassium Channel Openers. Modifications on the Western Region

Cyrus John Ohnmacht; Keith Russell; James Roy Empfield; C.A. Frank; Keith Hopkinson Gibson; Daniel Ray Mayhugh; Frances M. Mclaren; Howard S. Shapiro; Frederick Jeffrey Brown; Diane Amy Trainor; Christopher Ceccarelli; Margaret M. Lin; Brian B. Masek; Janet Marie Forst; Robert Joseph Harris; James Hulsizer; Joseph James Lewis; Stuart M. Silverman; Reed W. Smith; Paul James Warwick; Sen T. Kau; Alexa L. Chun; Thomas L. Grant; Burton B. Howe; Jack H. Li; Shephali Trivedi; Tracy J. Halterman; Christopher Yochim; Martin C. Dyroff; M. Kirkland


Tetrahedron Letters | 2010

Efficient preparation of 2,4-methanoproline

Jeffrey G. Varnes; G. Scott Lehr; Gary Moore; James Hulsizer; Jeffrey S. Albert


Archive | 2009

Dibenzothiazepine derivatives and uses thereof - 424

Dean G. Brown; James R. Damewood; Phil Edwards; James Hulsizer; James Campbell Muir; M. Edward Pierson; Ashokkumar Bhikkappa Shenvi; Steven Wesolowski; Dan Widzowski; Michael W. Wood


Archive | 1995

QUINOLONE DERIVATIVE FOR TREATMENT OF URINARY INCONTINENCE

John Edward Warawa; Cyrus John Ohnmacht; Diane Amy Trainor; James Hulsizer


Archive | 2011

Derivado de dibenzotiazepina y sus usos

Dean G. Brown; James R. Damewood; Phil Edwards; James Hulsizer; James Campbell Muir; M. Edward Pierson; Askokkumar Bhikkappa Shenvi; Steven Wesolowski; Dan Widzowski; Michael W. Wood


Archive | 2010

COMPUESTO (R)-N*6*-ETIL-6,7-DIHIDRO-5H-INDENO(5,6-D)TIAZOL-2,6-DIAMINA Y SU USO COMO ANTIPSICOTICO

William C Iii Blackwell; James Hulsizer; Jian Wei Liu; Gary Steelman; Rebecca Urbanek; Dan Widzowski; Ye Wu


Archive | 2009

Dérivé de dibenzothiazépine et son utilisation

Dean G. Brown; James R. Damewood; Phil Edwards; James Hulsizer; James Campbell Muir; Jr. M. Edward Pierson; Ashokkumar Bhikkappa Shenvi; Steven Wesolowski; Dan Widzowski; Michael W. Wood


Archive | 2009

D2 Receptor Ligand-078

William Blackwell; James Hulsizer; Jianwei Liu; Gary Steelman; Rebecca Urbanek; Dan Widzowski; Ye Wu

Collaboration


Dive into the James Hulsizer's collaboration.

Researchain Logo
Decentralizing Knowledge